State Street’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Sell |
1,607,592
-145,087
| -8% | -$1.09M | ﹤0.01% | 2476 |
|
|
2025
Q1 | $13.3M | Sell |
1,752,679
-371,805
| -18% | -$2.81M | ﹤0.01% | 2356 |
|
|
2024
Q4 | $25.9M | Sell |
2,124,484
-212,738
| -9% | -$2.59M | ﹤0.01% | 2079 |
|
|
2024
Q3 | $39.1M | Buy |
2,337,222
+396,034
| +20% | +$6.63M | ﹤0.01% | 1828 |
|
|
2024
Q2 | $33.9M | Buy |
1,941,188
+515,729
| +36% | +$8.99M | ﹤0.01% | 1856 |
|
|
2024
Q1 | $24.3M | Buy |
1,425,459
+860,055
| +152% | +$14.7M | ﹤0.01% | 2100 |
|
|
2023
Q4 | $5.76M | Buy |
565,404
+43,508
| +8% | +$443K | ﹤0.01% | 2880 |
|
|
2023
Q3 | $4.72M | Sell |
521,896
-325
| -0.1% | -$2.94K | ﹤0.01% | 2945 |
|
|
2023
Q2 | $5.62M | Sell |
522,221
-39,993
| -7% | -$430K | ﹤0.01% | 2940 |
|
|
2023
Q1 | $5.75M | Buy |
562,214
+7,863
| +1% | +$80.4K | ﹤0.01% | 2939 |
|
|
2022
Q4 | $5.85M | Buy |
554,351
+52,835
| +11% | +$557K | ﹤0.01% | 2975 |
|
|
2022
Q3 | $6.43M | Buy |
501,516
+27,088
| +6% | +$347K | ﹤0.01% | 2938 |
|
|
2022
Q2 | $6.08M | Sell |
474,428
-607,109
| -56% | -$7.78M | ﹤0.01% | 2993 |
|
|
2022
Q1 | $11.3M | Sell |
1,081,537
-93,826
| -8% | -$982K | ﹤0.01% | 2755 |
|
|
2021
Q4 | $18.1M | Buy |
1,175,363
+812,404
| +224% | +$12.5M | ﹤0.01% | 2549 |
|
|
2021
Q3 | $8.19M | Buy |
362,959
+135,116
| +59% | +$3.05M | ﹤0.01% | 2990 |
|
|
2021
Q2 | $5.87M | Buy |
227,843
+33,028
| +17% | +$850K | ﹤0.01% | 3176 |
|
|
2021
Q1 | $8.12M | Buy |
+194,815
| New | +$8.12M | ﹤0.01% | 2836 |
|